News
CellCept (mycophenolate mofetil) is not safe to take while pregnant or breastfeeding. Certain factors, including the risks of fetal harm and pregnancy loss, may determine whether you should take ...
SAN FRANCISCO (MarketWatch) -- Aspreva Pharmaceuticals Corp. late Wednesday said the Food and Drug Administration has granted fast-track designation for CellCept for the treatment of lupus nephritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback